Without stones, there is no arch – Marco Polo

So the thinking goes. When an exciting technology emerges in a core market, strategic venture capitalists use equity to place an early bet, influence strategy and development, while thoughtfully protecting the downside by not committing fully via merger or acquisition. Assuming the technology is appropriately derisked via further development, a portfolio of early-stage investments provides the strategic with a high-value pipeline of acquisition targets and future growth.

Seems logical. Of course, I am sure many of my former colleagues in corporate venturing might argue that it is not quite that easy to convince their operating company partners that equity with no or soft rights is preferable to a more concrete research and development (R&D) or business development arrangement, but that is a topic for a separate conversation. 

The use…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?


Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Webinar: CVCs and the art of the follow-on
May 8, 2024
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)